(COST Action BM1007 WG1 Physiological and pathophysiological importance of mast cells and basophils in health and disease)
Ulrich Blank, PhD
INSERM, Paris, France
Late signaling events for histamine release by mast cells
Gunnar P. Nilsson, PhD
Karolinska Institutet, Solna, Sweden
Eicosanoids - performing lipidiomics on activated mast cells
Francesca Levi-Schaffer, PhD
The Hebrew University of Jerusalem, Jerusalem, Israel
The allergic effector unit: mast cells - eosinophils interactions regulate the allergic response
Ulrich Blank, PhD
CNRS Research Director
Inserm U699
Université Paris 7
Faculté de Médecine Site X. Bichat
16 rue Henri Huchard
75018 Paris, France
Fax: +33(0)157277661
e-mail: ulrich.blank(at)inserm.fr
Prof. Gunnar P. Nilsson, PhD
Karolinska Institutet
Department of Medicine Solna
Clinical Immunology and Allergy Unit
Karolinska University Hospital Solna L2:04
SE - 171 76 Stockholm, SWEDEN
Fax: +46 8 33 57 24
e-mail: gunnar.p.nilsson(at)ki.se
Prof. Francesca Levi-Schaffer, PhD
Institute for Drug Research, School of Pharmacy
Faculty of Medicine
The Hebrew University of Jerusalem
POB 12065
Jerusalem, 91120, Israel
Fax: +972-(2)-6758144
e-mail: fls(at)cc.huji.ac.il
The COST Action BM 1007 provides young and early stage researchers with individual support to conduct scientific und educational exchange between partner laboratories. For Short Term Scientific...
Belfast, Ireland, May 2-5, 2012
24-25th November, 2011, Southampton, UK. Mast Cells and Basophils as Targets for Innovative Therapies.